Save lives and prevent blindness
by using our AI technology
Get your results in less than a minute!
Less than 25% of the high risk population in the US are screened as the interpretation is expensive and impractical
Over 1B people need an annual check. USA: 75M (+84M prediabetics)
80% of diabetic patients develop DR within 15 years
Glaucoma is a leading cause of blindness after the age of 60
The risk of getting AMD is 30% for those over the age of 75
Zack Dvey-Aharon, PhD, CEO, Co-Founder
Serial entrepreneur, advisor, lecturer. Ph.D. in Machine Learning, 8200
Danny Margalit, COO, Co-Founder
Co-Founder Aladdin (NASDAQ IPO) Product & IP Expert
Izik Itzhakov,
VP Biz Dev
Over 20 years in Healthcare IT. CLEW, iMDsoft, 8200
Amit Wohl,
VP Clinical Studies
Seasoned technology expert
MSc, MBA MIT, BSc Technion
​
Contact Us
To learn more about AEYE Health, our technology, our solution and any other inquiry, please fill the following form or send an email to info@aeyehealth.com.
New York
200 Park Avenue New York, 17th floor, 10166
​
Call us at: 1 866 262 7343
Tel Aviv
28 HaArba'a street, South Building, 30th floor. 6473925
​
Yiannis Monovoukas, PhD
Sean Ianchulev, MD, MPH
Stephen Remondi
Helios Global Investments, Falcon Ventures. CEO of TEI Biosciences, Acquired for $312M
Serial Investor, CEO at Eyenovia
Professor of Ophthalmology at UCSF & Mt. Sinai
Serial Investor, CEO at Xsphera
Board of advisors at Tufts, Partner at R-Cubed
Mike Netz
Serial Angel Investor
Former CEO of Teva Israel